13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q2 2023. See the latest, Q2 2026 →
Reported value
$527.49B
+4.5% on the quarter before
Positions
1,795
127 new · 314 sold out
Top 10
20.0%
of the value
Est. gain
+$26.26B
on stocks held all quarter
Est. return
+5.7%
on those stocks since Q1 2023
Positions as of Jun 30, 2023, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 32% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2023. Striped tiles are options.
Largest buys
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Nvidia~$1.23BAdded · 0.4% → 0.8%+2,912,739 shares
- Merck & Co Inc~$1.00BAdded · 1.4% → 1.7%+8,681,935 shares
- Abbott Labs~$991.0MAdded · 0.4% → 0.6%+9,090,340 shares
- Gilead Sciences Inc~$966.4MAdded · 0.1% → 0.2%+12,539,306 shares
- Amazon~$920.3MAdded · 1.6% → 2.0%+7,059,481 shares
- Alphabet~$846.9MAdded · 1.7% → 2.1%+7,075,243 shares
- Broadcom~$784.1MAdded · 0.2% → 0.5%+903,889 shares
- Apple~$759.5MAdded · 1.9% → 2.3%+3,915,347 shares
- Pnc Finl Svcs Group Inc~$742.9MAdded · 0.2% → 0.3%+5,898,334 shares
- S&P Global Inc~$632.2MAdded · 0.3% → 0.5%+1,577,012 shares
Largest sells
Since Q1 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Eli Lilly~$2.75BCut · 1.4% → 1.3%−5,872,958 shares
- Morgan Stanley~$909.0MCut · 0.8% → 0.6%−10,644,075 shares
- Seagen Inc~$880.6MCut · 0.3% → 0.1%−4,575,730 shares
- Schwab Charles Corp~$733.7MCut · 0.3% → 0.2%−12,944,041 shares
- Arista Networks~$725.6MCut · 0.2% → 0.0%−4,477,062 shares
- Coca Cola Co~$721.1MCut · 0.7% → 0.5%−11,974,287 shares
- Sysco Corp~$677.6MCut · 0.5% → 0.3%−9,132,509 shares
- Mcdonalds Corp~$666.0MCut · 0.9% → 0.7%−2,231,673 shares
- Stryker Corporation~$595.4MCut · 0.9% → 0.8%−1,951,500 shares
- Hca Healthcare Inc~$587.3MCut · 0.7% → 0.6%−1,935,280 shares
Holdings
As of Jun 30, 2023. Changes are in shares against Mar 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +1.4% · price +18.1% | 4.3% | $22.80B | +$3.45B | ||||||||
| AppleCOM · shares +6.8% · price +17.6% | 2.3% | $11.90B | +$1.67B | ||||||||
| Unitedhealth Group IncCOM · shares +2.5% · price +1.7% | 2.2% | $11.87B | +$193.8M | ||||||||
| AlphabetCAP STK CL A · shares +8.4% · price +15.4% | 2.1% | $10.94B | +$1.35B | ||||||||
| AmazonCOM · shares +9.3% · price +26.2% | 2.0% | $10.81B | +$2.05B | ||||||||
| Merck & Co IncCOM · shares +13% · price +8.5% | 1.7% | $8.91B | +$617.1M | ||||||||
| Pfizer IncCOM · shares +6.5% · price −10.1% | 1.6% | $8.55B | −$902.0M | ||||||||
| MetaCL A · shares +1.7% · price +35.4% | 1.3% | $6.80B | +$1.75B | ||||||||
| Eli LillyCOM · shares −29% · price +36.6% | 1.3% | $6.78B | +$1.81B | ||||||||
| Tjx Cos Inc NewCOM · shares −3.8% · price +8.2% | 1.2% | $6.38B | +$484.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares +1.6% · price +11.6% | 1.0% | $5.50B | +$563.4M | ||||||||
| Danaher CorporationCOM · shares +7.0% · price −4.8% | 0.96% | $5.05B | −$236.5M | ||||||||
| MastercardCL A · shares −4.6% · price +8.2% | 0.95% | $5.00B | +$380.1M | ||||||||
| Procter And Gamble CoCOM · shares −3.6% · price +2.1% | 0.94% | $4.94B | +$99.3M | ||||||||
| ConocophillipsCOM · shares +4.2% · price +4.4% | 0.92% | $4.83B | +$196.8M | ||||||||
| Visa Inc.COM CL A · shares −6.6% · price +5.3% | 0.91% | $4.78B | +$241.9M | ||||||||
| Texas InstrumentsCOM · shares −7.4% · price −3.2% | 0.91% | $4.78B | −$158.9M | ||||||||
| Home Depot IncCOM · shares −7.1% · price +5.3% | 0.86% | $4.53B | +$226.5M | ||||||||
| NvidiaCOM · shares +39% · price +52.3% | 0.83% | $4.37B | +$1.08B | ||||||||
| Stryker CorporationCOM · shares −12% · price +6.9% | 0.82% | $4.33B | +$278.7M | ||||||||
| Honeywell TechnologiesCOM · shares −4.0% · price +8.6% | 0.80% | $4.23B | +$334.3M | ||||||||
| American Express CoCOM · shares +5.2% · price +5.6% | 0.76% | $4.03B | +$203.5M | ||||||||
| Mcdonalds CorpCOM · shares −14% · price +6.7% | 0.75% | $3.94B | +$248.5M | ||||||||
| Raytheon Technologies CorpCOM · shares −4.1% · price +0.0% | 0.73% | $3.85B | +$1.2M | ||||||||
| Johnson & JohnsonCOM · shares −9.6% · price +6.8% | 0.72% | $3.80B | +$241.5M | ||||||||
| Total · 1,795 positions | 100% | $527.49B | +$26.26B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2023 to Q2 2023: 1,574 stocks held throughout, up $26.26B (+5.7%).
- Microsoft+$3.45B+18%
- Amazon+$2.05B+26%
- Eli Lilly+$1.81B+37%
- Meta+$1.75B+35%
- Apple+$1.67B+18%
- Illumina Inc−$202.0M−19%
- Danaher Corporation−$236.5M−5%
- Humana Inc−$262.5M−8%
- Nike Inc−$351.6M−10%
- Pfizer Inc−$902.0M−10%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |